Myriad Genetics Inc (MYGN)

EBITDA Margin

-13.63%

Quarterly · Period ending:

MYGN logo

MYGN EBITDA Margin

Latest reported-13.63%
MYGN Quarterly EBITDA Margin (100.00% → -13.63%)
High-resolution chart · PNG

MYGN ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-13.634%
-8.7325%
3.8608%
-4.7642%
-147.8179%
-7.2486%
-11.2061%
-2.2504%
-10.0709%
-4.7972%
-8.2909%
-24.0229%
-55.7493%
-18.0464%
-21.0911%
-19.3734%
-2.454%
-7.5804%
-18.4701%
32.9348%
7.9725%
-16.2912%
0%
-15.9091%
-40.4506%
-67.622%
4.7668%
-0.6441%
6.4531%
11.4497%
11.5314%
10.5289%
13.4941%
14.6368%
10.3246%
54.4183%
16.6085%
11.3763%
14.0458%
7.831%
22.6931%
26.0367%
26.7977%
27.3025%
22.5448%
23.3889%
22.9393%
18.8981%
31.1401%
32.1265%
41.8691%
42.1185%
39.1523%
38.4081%
38.7756%
38.0652%
37.3136%
37.294%
38.8858%
39.4914%
40.6426%
42.6124%
40.1932%
40.6584%
41.9545%
38.5368%
39.0835%
36.9951%
93.2086%
43.5312%
42.4802%
21.1378%
41.0372%
-8.9517%
-11.577%
-19.7116%
-22.556%
-17.4201%
35.5271%
-39.4807%
-38.0234%
-34.342%
-28.9389%
-33.4873%
-27.5713%
-46.0247%
-46.535%
-54.6439%
-62.7853%
-70.5946%
-63.2316%
-63.9921%
-40.5502%
-29.9416%
-35.9011%
-30.7911%
-44.2642%
-24.7627%
-20.4672%
-14.5944%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.